Učitavanje...
cGMP modulation therapeutics for sickle cell disease
Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide each year a...
Spremljeno u:
| Izdano u: | Exp Biol Med (Maywood) |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405827/ https://ncbi.nlm.nih.gov/pubmed/30691292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219827276 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|